confid target price reiter
outperform rate top-pick ew
ew remain high convict top pick signific potenti upsid weve
updat differenti two-stag valuat model ew support potenti
upsid ew next month boost confid
target price target price reflect potenti upsid current
level valuat scenario impli potenti upsid
updat valuat analysi support view stock reach exceed
target price next month potenti reach scenario valu
reiter outperform rate target price expect ew
continu substanti outperform univers market
differenti two-stag valuat approach suggest ew exceed
price two-stag valuat approach base ew yr rel
ev/ebitda multipl around twice multipl combin
impact per share bil increas consensu expect ww tavr
market updat model suggest support ew reach next
month target price line
valuat scenario light updat analysi view target
reason conserv
management guidanc tavr leav open upper teen growth
compani tavr guidanc present ew recent analyst day highli anticip
close watch ww tavr outlook interpret slightli better
low double-digit commentari given earn call said note
dollar rang ww tavr guidanc present management bil actual
suggest growth high end rang report cc view
updat outlook posit came away year meet greater
convict expect continu strong growth us tavr market potenti drive
addit upward revis street estim throughout
valuat metric
number share
 close
legal entiti disclosur statu non-u analyst us disclosur credit suiss seek busi
compani cover research report result investor awar firm may conflict interest could
affect object report investor consid report singl factor make invest decis
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
global manufactur provid
medic devic equip structur valvular heart diseas
critic care
one-year valuat scenario base
ev/ebitda ebitda
scenario base emerg segment deliv growth
high-growth segment grow growth grow
one-year valuat grey scenario base
ev/ebitda grey ebitda grey
scenario base emerg segment deliv growth
high-growth segment grow growth grow
 close
continu view rise investor confid size lt tavr market
signific driver ew intermediate- long-term stock perform expect
increas sinc risk tavr result present march surprisingli strong
us tavr growth report ew estim street estim
tavr market bil around bil earli pleas see
investor sentiment survey said continu fundament healthi debat
potenti long-term size market well wide rang view
mani patient new us low-risk indic reach
mind updat differenti two-stag valuat model ew
combin baselin stage valu project increas equiti valu per share
creat consensu estim rise next month base histor
ev/ebitda averag multipl rel ew trade roughli
 multipl forward ebitda see figur use current ntm ev/ebitda
multipl would equat baselin ev/ebitda multipl
averag valuat market discount stock base current consensu estim
long-term tavr market ew use bil ebitda project
would suggest baselin stage valu per share view
baselin valu stock assum consensu tavr expect remain
bil consist averag consensu expect past year
base estim bil increas consensu long-term tavr market
project equat per share ew see figur increas tavr
expect past year bil bil support increas valuat
 per share expect consensu estim
long-term tavr market rise anoth bil next month driven rise
confid continu growth market penetr heel new low-risk
indic favor clinic data tavr low-risk patient present march
put togeth valuat model suggest stage increment could drive
stock current level high per share
therefor view price target reason potenti conserv
figur ew rel valuat vs
analysi summar estim potenti impact ew stock price
bil increas consensu expect ww tavr market assum
analysi ew hold ww market share declin ew current share
appli increment op margin addit tavr share appli
baselin ev/ebitda multipl roughli market multipl consist
averag equat increment target
stock base bil rise project tavr market expect
figur ew stock price sensit chang lt tavr market expect
valuat target price base ev/ebitda multipl bil
ebitda estim risk product delay unexpect share loss potenti litig
estim mm except per share data lt tavr market project tavr market market share project ebit ebitda mult target /share impact charl martineau pm univers toronto januari
compani mention price
matt miksic vik chopra certifi respect compani secur individu analyz view express
report accur reflect person view subject compani secur part
compens directli indirectli relat specif recommend view express report
